Glioma stem cells (GSCs) are the core cause of tumor growth, angiogenesis, and therapeutic resistance in GBM.[61] According to transcriptome data, SOX9, a GSC driving factor, was strongly upregulated. The gene discussed is SOX9; the disease is central nervous system cancer.